H. erinaceus supplementation improved cognitive performance and subjective outcomes in adults with cognitive difficulty.
This was a randomized, double-blind, placebo-controlled trial conducted remotely. The population included 109 adults aged 40 to 75 years with self-reported cognitive difficulty. Participants were assigned to receive 2 g of H. erinaceus fruiting body and mycelial biomass or a placebo daily for eight weeks, following a one-week baseline.
The primary outcome was cognitive performance using a computerized battery. The intervention group showed significantly greater improvement in visual attention and working memory (Juggle Factor task) compared to placebo (p < 0.05). Secondary outcomes also showed significantly greater improvement with H. erinaceus for subjective sleep quality, morning restedness, mood, and subjective wellbeing (all p < 0.05).
No adverse events were reported in participants receiving H. erinaceus. Serious adverse events and discontinuations were not reported.
Key limitations include the remote setting and the lack of reported effect sizes or absolute numbers for the outcomes. The study was not designed to establish causality, and the findings are based on a specific dose and formulation. Practice relevance is limited to this population and intervention context.